Literature DB >> 26738341

Postoperative cognitive dysfunction and Alzheimer disease.

Berrin Işik.   

Abstract

Alzheimer disease (AD) is the most prevalent neurodegenerative disorder in elderly people. Patients with AD appear to be particularly at risk for cognitive deterioration following anesthesia. Some in vitro studies suggest that exposure to general anesthesia (GA) promotes the AD process. On the other hand, there are no clinical studies that clearly demonstrate that GA is a cause of cognitive dysfunction in patients with probable AD. The aim of this research was to discuss the relation between postoperative cognitive dysfunction (POCD) and AD according to the literature. In vivo studies examining AD biomarkers postoperatively and in vitro studies exploring amyloid-β (Aβ) converge to indicate that anesthetics could affect AD pathogenesis, either directly or indirectly. Careful evaluation of the mental state should be mandatory for all elderly patients undergoing GA. Long-term prospective, randomized clinical studies are required to examine the relationship between POCD and AD.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26738341     DOI: 10.3906/sag-1405-87

Source DB:  PubMed          Journal:  Turk J Med Sci        ISSN: 1300-0144            Impact factor:   0.973


  3 in total

Review 1.  General Anesthetic Use in Fragile X Spectrum Disorders.

Authors:  Andrew Ligsay; Marwa El-Deeb; Maria J Salcedo-Arellano; Nina Schloemerkemper; Jeremy S Grayson; Randi Hagerman
Journal:  J Neurosurg Anesthesiol       Date:  2019-07       Impact factor: 3.956

2.  The risk factors for cognitive dysfunction in elderly patients after laparoscopic surgery: A retrospective analysis.

Authors:  Yan Fan; Xinru Liu; Shanshan Wu; Yan Liu
Journal:  Medicine (Baltimore)       Date:  2021-01-15       Impact factor: 1.817

3.  Stress Granules Modulate SYK to Cause Tau-Associated Neurocognitive Deterioration in 5XFAD Mouse After Anesthesia and Surgery.

Authors:  Yang Shen; Tong Zhang; Yinglin Zhang; Yinuo Wang; Junyan Yao
Journal:  Front Aging Neurosci       Date:  2021-08-27       Impact factor: 5.750

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.